Wright Don - 11 Jun 2024 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Reporting relationship
Director
Issuer ticker
ISCO
Reported as of
11 Jun 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Jun 2024, 16:05:50 UTC
Prior SEC filing
16 Jun 2023
Next SEC filing
20 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Russell Kern, as Attorney-in-Fact

Key filing fact

Wright Don filed Form 4 for International Stem Cell CORP (ISCO) on 13 Jun 2024.

Key facts

  • This page summarizes Wright Don's Form 4 filing for International Stem Cell CORP (ISCO).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Jun 2024, 16:05.

Change

  • Previous filing in this sequence was filed on 16 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISCO.OB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+30,000
Change %
Price
$0.000000
Shares after
30,000
Date
11 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,000
Exercise price
$0.1200
Footnotes
F1
ISCO.OB transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+361,111
Change %
Price
$0.000000
Shares after
361,111
Date
11 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
361,111
Exercise price
$0.1200
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Options shall vest on the earlier of (i) June 11, 2025 or (ii) the date of the 2025 Annual Meeting of Stockholders.

Footnote F2

Options shall vest in four equal quarterly increments, beginning September 11, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .